The periprocedural and 30-day outcomes of carotid stenting in patients with carotid artery near-occlusion
Abstract The safety of endovascular revascularization in patients with carotid artery near occlusion (CANO) is unknown. We aimed to evaluate the peri-procedural risk in CANO patients receiving carotid artery stenting (CAS). A prospective data base with retrospective review was performed to identify...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/90a1366eb65a473c886492e61a39f901 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:90a1366eb65a473c886492e61a39f901 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:90a1366eb65a473c886492e61a39f9012021-11-14T12:18:55ZThe periprocedural and 30-day outcomes of carotid stenting in patients with carotid artery near-occlusion10.1038/s41598-021-01286-32045-2322https://doaj.org/article/90a1366eb65a473c886492e61a39f9012021-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-01286-3https://doaj.org/toc/2045-2322Abstract The safety of endovascular revascularization in patients with carotid artery near occlusion (CANO) is unknown. We aimed to evaluate the peri-procedural risk in CANO patients receiving carotid artery stenting (CAS). A prospective data base with retrospective review was performed to identify patients who underwent CAS with CANO from July 2006 to July 2020, and had at least 1-month clinical follow-up data. The primary endpoints were stroke, hyperperfusion syndrome, and death within 30 days after CAS. A total of 198 patients with carotid artery stenosis were enrolled including 92 patients with CANO and 106 age and sex-matched patients with 70–99% conventional carotid stenosis. Full distal carotid collapse was found in 45 CANO patients (45/92, 49%). The technical success rate was 100%. The CANO patients had significantly longer lesion lengths compared with those of the non-CANO group. The incidence of hyperperfusion syndrome was comparable (CANO: 2.2%, non-CANO: 0.9%, P = 0.598). The risks of ischemic stroke and death within 30 days were 1.1% and 0% in the CANO group; and 1.9% and 0.9%, in the non-CANO group, respectively, without statistical difference. In conclusion, CAS is safe for patients with CANO, with a similar low 30-day peri-procedural event rate comparable to those of non-CANO.Cheng-Hsuan TsaiYing-Hsien ChenMao-Shin LinChing-Chang HuangChi-Sheng HungChih-Fan YehSheng-Fu LiuSung-Chun TangChi-Chao ChaoHsien-Li KaoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-7 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Cheng-Hsuan Tsai Ying-Hsien Chen Mao-Shin Lin Ching-Chang Huang Chi-Sheng Hung Chih-Fan Yeh Sheng-Fu Liu Sung-Chun Tang Chi-Chao Chao Hsien-Li Kao The periprocedural and 30-day outcomes of carotid stenting in patients with carotid artery near-occlusion |
description |
Abstract The safety of endovascular revascularization in patients with carotid artery near occlusion (CANO) is unknown. We aimed to evaluate the peri-procedural risk in CANO patients receiving carotid artery stenting (CAS). A prospective data base with retrospective review was performed to identify patients who underwent CAS with CANO from July 2006 to July 2020, and had at least 1-month clinical follow-up data. The primary endpoints were stroke, hyperperfusion syndrome, and death within 30 days after CAS. A total of 198 patients with carotid artery stenosis were enrolled including 92 patients with CANO and 106 age and sex-matched patients with 70–99% conventional carotid stenosis. Full distal carotid collapse was found in 45 CANO patients (45/92, 49%). The technical success rate was 100%. The CANO patients had significantly longer lesion lengths compared with those of the non-CANO group. The incidence of hyperperfusion syndrome was comparable (CANO: 2.2%, non-CANO: 0.9%, P = 0.598). The risks of ischemic stroke and death within 30 days were 1.1% and 0% in the CANO group; and 1.9% and 0.9%, in the non-CANO group, respectively, without statistical difference. In conclusion, CAS is safe for patients with CANO, with a similar low 30-day peri-procedural event rate comparable to those of non-CANO. |
format |
article |
author |
Cheng-Hsuan Tsai Ying-Hsien Chen Mao-Shin Lin Ching-Chang Huang Chi-Sheng Hung Chih-Fan Yeh Sheng-Fu Liu Sung-Chun Tang Chi-Chao Chao Hsien-Li Kao |
author_facet |
Cheng-Hsuan Tsai Ying-Hsien Chen Mao-Shin Lin Ching-Chang Huang Chi-Sheng Hung Chih-Fan Yeh Sheng-Fu Liu Sung-Chun Tang Chi-Chao Chao Hsien-Li Kao |
author_sort |
Cheng-Hsuan Tsai |
title |
The periprocedural and 30-day outcomes of carotid stenting in patients with carotid artery near-occlusion |
title_short |
The periprocedural and 30-day outcomes of carotid stenting in patients with carotid artery near-occlusion |
title_full |
The periprocedural and 30-day outcomes of carotid stenting in patients with carotid artery near-occlusion |
title_fullStr |
The periprocedural and 30-day outcomes of carotid stenting in patients with carotid artery near-occlusion |
title_full_unstemmed |
The periprocedural and 30-day outcomes of carotid stenting in patients with carotid artery near-occlusion |
title_sort |
periprocedural and 30-day outcomes of carotid stenting in patients with carotid artery near-occlusion |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/90a1366eb65a473c886492e61a39f901 |
work_keys_str_mv |
AT chenghsuantsai theperiproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion AT yinghsienchen theperiproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion AT maoshinlin theperiproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion AT chingchanghuang theperiproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion AT chishenghung theperiproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion AT chihfanyeh theperiproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion AT shengfuliu theperiproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion AT sungchuntang theperiproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion AT chichaochao theperiproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion AT hsienlikao theperiproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion AT chenghsuantsai periproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion AT yinghsienchen periproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion AT maoshinlin periproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion AT chingchanghuang periproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion AT chishenghung periproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion AT chihfanyeh periproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion AT shengfuliu periproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion AT sungchuntang periproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion AT chichaochao periproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion AT hsienlikao periproceduraland30dayoutcomesofcarotidstentinginpatientswithcarotidarterynearocclusion |
_version_ |
1718429301067481088 |